• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Vice-President Ernest Douglas Bryan was granted 5,628 shares and covered exercise/tax liability with 4,678 shares, increasing direct ownership by 2% to 45,786 units (SEC Form 4)

    2/25/25 3:03:04 PM ET
    $UBSI
    Major Banks
    Finance
    Get the next $UBSI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Ernest Douglas Bryan

    (Last) (First) (Middle)
    514 MARKET ST

    (Street)
    PARKERSBURG WV 26101

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    UNITED BANKSHARES INC/WV [ UBSI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Vice-President
    3. Date of Earliest Transaction (Month/Day/Year)
    02/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/22/2025 02/22/2025 A 5,628(1) A $0.0000 50,463.9031 D
    Common Stock 02/22/2025 02/22/2025 F 586 D $35.53 49,877.9031 D
    Common Stock 02/22/2025 02/22/2025 F 747 D $35.53 49,130.9031 D
    Common Stock 02/22/2025 02/22/2025 F 2,807 D $35.53 46,323.9031 D
    Common Stock 02/23/2025 02/23/2025 F 538 D $35.53 45,785.9031 D
    Common Stock 7,388.5658 I(2) By 401k
    Common Stock 79 I By Spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option $32.51 02/24/2020 02/24/2030 Common Stock 7,295 7,295 D
    Stock Option $32.51 02/24/2021 02/24/2030 Common Stock 3,647 3,647 D
    Stock Option $35.04 02/29/2016 02/28/2026 Common Stock 5,000 5,000 D
    Stock Option $37.6 02/26/2018 02/26/2028 Common Stock 7,676 7,676 D
    Stock Option $38.49 02/25/2019 02/25/2029 Common Stock 5,455 5,455 D
    Stock Option $45.3 02/27/2017 02/27/2027 Common Stock 7,676 7,676 D
    Explanation of Responses:
    1. Represents performance-based restricted stock units granted in February 2022 that vested in February 2025 upon achievement of performance goals. The restricted stock units were settled by delivery of an equal number of shares of common stock.
    2. Includes additional shares acquired under the UBSI 401K plan since the date of the reporting person's last 401K ownership report.
    Shelli L. Adams 02/25/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $UBSI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UBSI

    DatePrice TargetRatingAnalyst
    3/12/2025$38.50Neutral
    Piper Sandler
    4/4/2023$32.00Equal-Weight
    Stephens
    12/21/2022$44.00Outperform
    Raymond James
    12/5/2022$45.00Neutral
    Piper Sandler
    9/6/2022$40.00Buy
    Janney
    12/15/2021$44.00 → $38.00Buy → Neutral
    DA Davidson
    10/27/2021$39.00 → $40.00Outperform
    Raymond James
    7/26/2021$42.00 → $39.00Outperform
    Raymond James
    More analyst ratings